Land This Deal Even Lower Than Director Pierce Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 12, Voyager Therapeutics Inc's Director, Glenn Pierce, invested $92,200.00 into 5,000 shares of VYGR, for a cost per share of $18.44..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.